{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:28:42Z","timestamp":1785796122534,"version":"3.56.0"},"reference-count":100,"publisher":"Wiley","issue":"20","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The catabolic autophagy eliminates cytoplasmic components and organelles via lysosomes. Non\u2010selective bulk autophagy and selective autophagy (mitophagy) are linked in intracellular homeostasis both normal and cancer cells. Autophagy has complex and paradoxical dual role in cancers; it can play either tumour suppressor or tumour promoter depending on the tumour type, stage, microenvironment and genetic context. Cancer stem cells (CSCs) cause tumour recurrence and promote resistant to therapy for driving poor clinical consequences. Thus, new healing strategies are urgently needed to annihilate and eradicate CSCs. As chloroquine (CQ) analogues show positive clinical outcome in several clinical trials either standalone or combination with several chemotherapies. Moreover, CQ analogues are known to eliminate CSCs via altering DNA methylation. However, several obstacles such as higher concentrations and dose\u2010dependent toxicity are noticeable in the treatment of cancers. As tumour cells predominantly rely on mitochondrial actions, mitochondrial targeting FDA\u2010approved antibiotics are reported to effectively eradicate CSCs alone or combination with chemotherapy. However, antibiotics cause metabolic glycolytic shift in cancer cells for survival and repopulation. This review will provide a sketch of the inhibiting roles of current chloroquine analogues and antibiotic combination in CSC autophagy process and discuss the possibility that pre\u2010clinical and clinical potential therapeutic strategy for anticancer therapy.<\/jats:p>","DOI":"10.1111\/jcmm.15879","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T15:24:26Z","timestamp":1601047466000},"page":"11667-11679","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Co\u2010targeting of lysosome and mitophagy in cancer stem cells with chloroquine analogues and antibiotics"],"prefix":"10.1111","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-3662","authenticated-orcid":false,"given":"Md. Abdul Alim","family":"Al\u2010Bari","sequence":"first","affiliation":[{"name":"Department of Pharmacy University of Rajshahi  Rajshahi Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30382"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30677-0"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70211-5"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.71"},{"key":"e_1_2_10_6_1","first-page":"135","article-title":"Biotherapeutic approaches to target cancer stem cells","volume":"8","author":"Duggal R","year":"2014","journal-title":"J Stem Cells"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2015.08.014"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2014.07.001"},{"issue":"1101","key":"e_1_2_10_9_1","first-page":"1110","article-title":"Cancer stem cells: Implications for cancer therapy","volume":"28","author":"Dawood S","year":"2014","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2789"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4401"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2016.01.012"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","unstructured":"The Pharmaceutical Journal.Return on investment falls for pharmaceutical industry.2017.https:\/\/doi.org\/10.1211\/PJ.2017.20202146","DOI":"10.1211\/PJ.2017.20202146"},{"key":"e_1_2_10_14_1","first-page":"1","article-title":"Global medicines use in 2020: outlook and implications","volume":"2015","author":"Aitken M","year":"2020","journal-title":"IMS Institute for healthcare informatics"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00273"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0642-x"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2016.51"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1468"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2011.04.003"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.22"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13160"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14305"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-020-00746-0"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(04)00099-1"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1666"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113466"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020091"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.048"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9131397"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00138"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73941"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2966"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.350"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/603980"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i1.50"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3802"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/45257"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology9010004"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20039"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2436255100"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1999.5851"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-98"},{"issue":"2","key":"e_1_2_10_43_1","first-page":"2441","article-title":"Effects of Beclin 1 overexpression on aggressive phenotypes of colon cancer cells","volume":"17","author":"Zhang M\u2010Y","year":"2019","journal-title":"Oncol Lett"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.6.3.11303"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2010.02.001"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-13-0614"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008558"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.01.008"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.06.001"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402030"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1039\/C8TB03165G"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9873-4"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006251"},{"key":"e_1_2_10_54_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/brv.12337","article-title":"The interplay between autophagy and tumorigenesis: Exploiting autophagy as a means of anticancer therapy","volume":"93","author":"Lorente J","year":"2017","journal-title":"Biol Rev Camb Philos Soc"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.53"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.10.034"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.99"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1025731"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0132"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv018"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78652"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-9-13"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.04.002"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1746"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0948"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.29119"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119465"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.29428"},{"key":"e_1_2_10_69_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-014-1686-9","article-title":"Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells","volume":"122","author":"Hori YS","year":"2014","journal-title":"J Neurooncol"},{"key":"e_1_2_10_70_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2015.12.017","article-title":"Time to use a dose of chloroquine as an adjuvant to anti\u2010cancer chemotherapies","volume":"771","author":"Pascolo S","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"e_1_2_10_71_1","first-page":"2959","article-title":"Targeting the cytotoxicity of topoisomerase ii\u2010directed epipodophyllotoxins to tumor cells in acidic environments","volume":"54","author":"Jensen PB","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.28984"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.4161\/23723548.2014.970097"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2007.03.034"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2017-0110"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2016-0210"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.04.009"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2011.08.001"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.02.011"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23171"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0490"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.04.008"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.199"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10933"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1425058"},{"key":"e_1_2_10_86_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mito.2015.12.007","article-title":"Mitochondria: An intriguing target for killing tumour\u2010initiating cells","volume":"26","author":"Yan B","year":"2015","journal-title":"Mitochondrion"},{"key":"e_1_2_10_87_1","first-page":"617","article-title":"Dual role of mitophagy in cancer drug resistance","volume":"38","author":"Yan C","year":"2018","journal-title":"Anticancer Res"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3174"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.08.015"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.263"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006055"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100983"},{"key":"e_1_2_10_93_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2016.09.023","article-title":"Targeting cancer cells through antibiotics\u2010induced mitochondrial dysfunction requires autophagy inhibition","volume":"384","author":"Esner M","year":"2016","journal-title":"Cancer Lett"},{"key":"e_1_2_10_94_1","first-page":"14","article-title":"Repurposing established compounds to target pancreatic cancer stem cells (cscs)","volume":"5","author":"Renz BW","year":"2017","journal-title":"Med Sci (Basel)"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.015"},{"key":"e_1_2_10_96_1","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.4238\/2014.April.14.8","article-title":"Azithromycin enhances the favorable results of paclitaxel and cisplatin in patients with advanced non\u2010small cell lung cancer","volume":"13","author":"Chu DJ","year":"2014","journal-title":"Genet Mol Res"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.59"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12308"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5852"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.2492\/inflammregen.32.222"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11400"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.15879","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcmm.15879","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.15879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T21:23:14Z","timestamp":1693862594000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcmm.15879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":100,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1111\/jcmm.15879"],"URL":"https:\/\/doi.org\/10.1111\/jcmm.15879","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"2019-08-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}